Status:
COMPLETED
Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients
Lead Sponsor:
University of Turin, Italy
Collaborating Sponsors:
Ministry of Health, Italy
Conditions:
Type 2 Diabetes Mellitus
Inflammation
Eligibility:
All Genders
35-85 years
Phase:
PHASE3
Brief Summary
This research will investigate the effect of resveratrol on inflammatory mediators in type 2 diabetic patients in vivo. The investigators will also investigate the hypothesis that resveratrol has an ...
Detailed Description
Despite a large body of evidence demonstrating promising effects of resveratrol in rodents, human studies are still lacking and both preventive and therapeutic value of resveratrol in humans remains t...
Eligibility Criteria
Inclusion
- 35 years of age and older
- Type 2 diabetes with body mass index (BMI)\<35 kg/m2
- Subjects on hypoglycemic agents other than insulin
- Willing to give written informed consent and able to understand, to participate in and to comply with the study requirements.
Exclusion
- Subjects on any antioxidant medication
- Patient on non-steroidal anti-inflammatory drug, steroids or insulin
- On any agent with significant antioxidant properties
- History of drug or alcohol abuse
- Liver or kidney diseases
- Any life threatening diseases
- Allergy to peanuts, grapes, wine, mulberries
- Pregnant women
- Coronary event or procedure (myocardial infarction, unstable angina, coronary artery bypass surgery or coronary angioplasty) in the previous four Weeks
- Subjects on anticoagulants
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT02244879
Start Date
October 1 2013
End Date
February 1 2016
Last Update
March 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Turin
Turin, IT, Italy, 10126